These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35341431)

  • 1. Epilepsy: expert opinion on emerging drugs in phase 2/3 clinical trials.
    Pong AW; Ross J; Tyrlikova I; Giermek AJ; Kohli MP; Khan YA; Salgado RD; Klein P
    Expert Opin Emerg Drugs; 2022 Mar; 27(1):75-90. PubMed ID: 35341431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future pharmacotherapy options for drug-resistant epilepsy.
    Elkommos S; Mula M
    Expert Opin Pharmacother; 2022 Dec; 23(18):2023-2034. PubMed ID: 36154780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epilepsy: key experimental therapeutics in early clinical development.
    Steriade C; French J; Devinsky O
    Expert Opin Investig Drugs; 2020 Apr; 29(4):373-383. PubMed ID: 32172604
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological diversity amongst approved and emerging antiseizure medications for the treatment of developmental and epileptic encephalopathies.
    Sills GJ
    Ther Adv Neurol Disord; 2023; 16():17562864231191000. PubMed ID: 37655228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
    Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
    CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics.
    Wilmshurst JM; Gaillard WD; Vinayan KP; Tsuchida TN; Plouin P; Van Bogaert P; Carrizosa J; Elia M; Craiu D; Jovic NJ; Nordli D; Hirtz D; Wong V; Glauser T; Mizrahi EM; Cross JH
    Epilepsia; 2015 Aug; 56(8):1185-97. PubMed ID: 26122601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Background of Epilepsy and Antiepileptic Treatments.
    Borowicz-Reutt K; Czernia J; Krawczyk M
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pediatric epilepsy: European expert opinion, 2007.
    Wheless JW; Clarke DF; Arzimanoglou A; Carpenter D
    Epileptic Disord; 2007 Dec; 9(4):353-412. PubMed ID: 18077226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development.
    Perucca E; White HS; Bialer M
    CNS Drugs; 2023 Sep; 37(9):781-795. PubMed ID: 37603261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pediatric epilepsy: expert opinion, 2005.
    Wheless JW; Clarke DF; Carpenter D
    J Child Neurol; 2005 Dec; 20 Suppl 1():S1-56; quiz S59-60. PubMed ID: 16615562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper.
    Villani F; Cianci V; Di Bonaventura C; Di Gennaro G; Galimberti CA; Guerrini R; La Neve A; Mecarelli O; Pietrafusa N; Specchio N; Vigevano F; Perucca E
    Expert Rev Neurother; 2022; 22(11-12):935-940. PubMed ID: 36662573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam, from broad-spectrum use to precision prescription: A narrative review and expert opinion.
    Celdran de Castro A; Nascimento FA; Beltran-Corbellini Á; Toledano R; Garcia-Morales I; Gil-Nagel A; Aledo-Serrano Á
    Seizure; 2023 Apr; 107():121-131. PubMed ID: 37023625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic advances in Dravet syndrome: a targeted literature review.
    Strzelczyk A; Schubert-Bast S
    Expert Rev Neurother; 2020 Oct; 20(10):1065-1079. PubMed ID: 32799683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review.
    Wheless JW
    Expert Rev Neurother; 2020 Nov; 20(11):1085-1098. PubMed ID: 33031714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies.
    Strzelczyk A; Schubert-Bast S
    CNS Drugs; 2021 Jan; 35(1):61-83. PubMed ID: 33479851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenfluramine for treatment-resistant epilepsy in Dravet syndrome and other genetically mediated epilepsies.
    Sullivan J; Simmons R
    Drugs Today (Barc); 2021 Jul; 57(7):449-454. PubMed ID: 34268532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of epilepsy: newly approved and developmental agents.
    Stephen LJ; Brodie MJ
    CNS Drugs; 2011 Feb; 25(2):89-107. PubMed ID: 21254787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication.
    Strzelczyk A; Schubert-Bast S
    CNS Drugs; 2022 Mar; 36(3):217-237. PubMed ID: 35156171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What has been the impact of new drug treatments on epilepsy?
    Chen Z; Brodie MJ; Kwan P
    Curr Opin Neurol; 2020 Apr; 33(2):185-190. PubMed ID: 32049739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.